Butyrylcholinesterase activity and molecular components in thymus of healthy and merosin-deficient Lama2dy mice

Neurochemistry International

Volumn 50, Issue 3, 2007, Pages 531-539

  Sánchez del Campo, Luis F ^a   Nieto Cerón, Susana ^a   Morote García, Julio C ^a   Muñoz Delgado, Encarnación ^a   Vidal, Cecilio J ^a   Campoy, Francisco J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cholinesterases; Congenital muscular dystrophy; Hydrophobic chromatography; Lectin binding

Indexed keywords

ACETYLCHOLINESTERASE; BUFFER; CHOLINESTERASE; DIMER; MEROSIN; MONOMER; PLANT LECTIN; TETRAMER; TRITON X 100;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BIOSYNTHESIS; CONTROLLED STUDY; GEL CHROMATOGRAPHY; LECTIN BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SEDIMENTATION; THYMUS;

ANIMALS; BUTYRYLCHOLINESTERASE; LAMININ; MICE; THYMUS GLAND;

MUS;

EID: 33846631413     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.11.001     Document Type: Article

References (56)

1. Agrawal B.B.L., and Goldstein I.J. Purification and properties of carbohydrate-binding proteins. Concanavalin A, the jack bean (Canavalia ensiformis) phytohemagglutinin. Methods Enzymol. 28 (1983) 313-317 Part B
2. Altamirano C.V., and Lockridge O. Conserved aromatic residues of the C-terminus of human butyrylcholinesterase mediate the association of tetramers. Biochemistry 38 (1999) 13414-13422
3. Bon S., Toutant J.P., Meflah K., and Massoulié J. Amphiphilic and nonamphiphilic forms of Torpedo acetylcholinesterase. I. Solubility and aggregation properties. J. Neurochem. 51 (1988) 776-785
4. 4 forms of acetylcholinesterase and butyrylcholinesterase in normal and dystrophic mouse muscle differ in their interaction with Ricinus communis agglutinin. Biochim. Biophys. Acta 1225 (1994) 283-288
5. Catalán R.E., Martínez A.M., Aragonés M.D., and Hernández F. Molecular forms of butyrylcholinesterase in rat brain microvessels. Neurosci. Lett. 120 (1990) 46-49
6. Cavallotti D., Artico M., Cavallotti C., Iannetti G., and Frati A. Acetylcholinesterase activity in rat thymus after immunostimulation with interleukin β. Ann. Anat. 182 (2000) 243-248
7. Cavallotti D., Artico M., Iannetti G., and Cavallotti C. Quantification of acetylcholinesterase-positive structures in human thymus during development and aging. Neurochem. Int. 36 (2000) 75-82
8. Cohen O., Kronman C., Velan B., and Shafferman A. Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta). Biochem. J. 378 (2004) 117-128
9. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Nat. Neurosci. 4 (2003) 131-138
10. De Jaco A., Augusti-Tocco G., and Biagioni S. Alternative acetylcholinesterase molecular forms exhibit similar ability to induce neurite outgrowth. J. Neurosci. Res. 70 (2002) 756-765
11. García-Ayllón M.S., Gómez J.L., and Vidal C.J. Amphiphilic properties of acetylcholinesterase monomers in mouse plasma. Neurosci. Lett. 265 (1999) 211-214
12. Gómez J.L., Moral-Naranjo M.T., Campoy F.J., and Vidal C.J. Characterization of acetylcholinesterase and butyrylcholinesterase forms in normal and dystrophic Lama2dy mouse heart. J. Neurosci. Res. 56 (1999) 295-306
13. Gómez J.L., García-Ayllón M.S., Campoy F.J., and Vidal C.J. Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2dy mice. J. Neurosci. Res. 62 (2000) 134-145
14. Gómez J.L., Nieto-Cerón S., Campoy F.J., Muñoz-Delgado E., and Vidal C.J. Purification and properties of hydrophilic dimers of acetylcholinesterase from mouse erythrocytes. Int. J. Biochem. Cell Biol. 35 (2003) 1109-1118
15. Greenfield S. A peptide derived from acetylcholinesterase is a pivotal signalling molecule in neurodegeration. Chemico-Biol. Interact. 157-158 (2005) 211-218
16. Grisaru D., Deutsch S.I., Shapira J., Pick M., Sternfeld M., Melamed-Book N., Kaufer D., Galyam N., Gait M.J., Owen D., Lessing J.B., Eldor A., and Soreq H. ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol. Med. 7 (2001) 93-105
17. Grunwald J., Marcus D., Papier Y., Raveh L., Pittel Z., and Ashani Y. Large-scale purification and long term stability of human butyrylcholinesterase: a potential bioscavenger drug. J. Biochem. Biophys. Methods 34 (1997) 123-135
18. Guglieri M., Magri F., and Comi G.P. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities. Clin. Chim. Acta 361 (2005) 54-79
19. Jiménez-Mallebrera C., Brown S.C., Sewry C.A., and Muntoni F. Congenital muscular dystrophy: molecular and cellular aspects. Cell. Mol. Life Sci. 62 (2005) 809-823
20. Layer P.G., and Willbold E. Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29 (1995) 1-94
21. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., and Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75 (2000) 1320-1331
22. Mack A., and Robitzki A. The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5′butyrylcholinesterase-DNA study. Prog. Neurobiol. 60 (2000) 607-628
23. Magner W.J., Chang A.C., Owens J., Hong M.J., Books A., and Coligan J.E. Aberrant development of thymocytes in mice lacking laminin-2. Dev. Immunol. 7 (2000) 179-193
24. Martínez-Moreno P., Nieto-Cerón S., Torres-Lanzas J., Ruiz-Espejo F., Tovar-Zapata I., Martínez-Hernández P., Rodríguez-López J.N., Vidal C.J., and Cabezas-Herrera J. Cholinesterase activity of human lung tumours varies according to their histological classification. Carcinogenesis 27 (2006) 429-436
25. Massoulié J. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11 (2002) 130-143
26. Mentlein R., and Kendall M.D. The brain and thymus have much in common: a functional analysis of their microenvironments. Immunol. Today 21 (2000) 133-139
27. Meshorer E., and Soreq H. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29 (2006) 216-224
28. Mihovilovic M., and Butterworth-Robinette J. Thymic epithelial cell line expresses transcripts encoding α-3, α-5 and β-4 subunits of acetylcholine receptors, responds to cholinergic agents and expresses choline acetyl transferase. An in vitro system to investigate thymic cholinergic mechanisms. J. Neuroimmunol. 17 (2001) 58-67
29. Miyagoe-Suzuki Y., Nakagawa M., and Takeda S. Merosin and congenital muscular dystrophy. Microsc. Res. Techn. 48 (2000) 181-191
30. Moral-Naranjo M.T., Cabezas-Herrera J., and Vidal C.J. Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. J. Neurosci. Res. 43 (1996) 224-234
31. Moral-Naranjo M.T., Campoy F.J., Cabezas-Herrera J., and Vidal C.J. Increased butyrylcholinesterase levels in microsomal membranes of dystrophic Lama2dy mouse muscle. J. Neurochem. 73 (1999) 1138-1144
32. Moral-Naranjo M.T., Cabezas-Herrera J., Vidal C.J., and Campoy F.J. Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice. Neurosci. Lett. 331 (2002) 155-158
33. Nachon F., Nicolet Y., Viguie N., Masson P., Fontecilla-Camps J.C., and Lockridge O. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization. Eur. J. Biochem. 269 (2002) 630-637
34. Nieto-Cerón S., Moral-Naranjo M.T., Muñoz-Delgado E., Vidal C.J., and Campoy F.J. Molecular properties of acetylcholinesterase in mouse spleen. Neurochem. Int. 45 (2004) 129-139
35. Nieto-Cerón S., Sánchez del Campo L.F., Muñoz-Delgado E., Vidal C.J., and Campoy F.J. Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice. J. Neurochem. 95 (2005) 1035-1046
36. Park S.E., Kim N.D., and Yoo Y.H. Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res. 64 (2004) 2652-2655
37. Patton B.L. Laminins of the neuromuscular system. Microsc. Res. Techn. 51 (2000) 247-261
38. Perry C., Sklan E.H., Birikh K., Shapira M., Trejo L., Eldor A., and Soreq H. Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21 (2002) 8428-8441
39. Rossi A., Vicini E., Scarsella G., and Biagioni S. Acetylcholinesterase distribution in subpopulations of murine thymocyte. J. Neurosci. Res. 29 (1991) 201-206
40. Ruiz-Espejo F., Cabezas-Herrera J., Illana J., Campoy F.J., and Vidal C.J. Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer. Breast Cancer Res. Treat. 72 (2002) 11-22
41. Sage H.J., and Green R.W. Purification and properties of carbohydrate-binding proteins. Common lentil (Lens culinaris). Methods Enzymol. 28 (1983) 332-339
42. Sasaki T., Giltay R., Talts U., Timpl R., and Talts J.F. Expression and distribution of laminin alpha 1 and alpha 2 chains in embryonic and adult tissues: an immunochemical approach. Exp. Cell Res. 275 (2002) 185-199
43. Saxena A., Hur R.S., Luo C., and Doctor B.P. Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain. Biochemistry 42 (2003) 15292-15299
44. Silman I., and Sussman J. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Curr. Opin. Pharmacol. 5 (2005) 293-302
45. Spencer M.J., and Tidball J.G. Do immune cells promote the pathology of dystrophin-deficient myopathies?. Neuromuscular Disord. 11 (2001) 556-564
46. Sternfeld M., Rachmilewitz J., Loewenstein-Lichtenstein Y., Andres C., Timberg R., Ben-Ari S., Glick C., Soreq H., and Zakut H. Normal and atypical butyrylcholinesterase in placental development, function, and malfunction. Cell. Mol. Neurobiol. 17 (1997) 315-332
47. Taylor P., and Radic Z. The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34 (1994) 281-320
48. Tomé F.M.S. The saga of congenital muscular dystrophy. Neuropediatrics 30 (1999) 55-65
49. Tornel P.L., Sáez-Valero J., and Vidal C.J. Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid. Neurosci. Lett. 145 (1992) 59-62
50. Ummenhofer W.C., Brown S.M., and Bernards C.M. Acetylcholinesterase and butyrylcholinesterase are expressed in the spinal meninges of monkeys and pigs. Anesthesiology 88 (1998) 1259-1265
51. Vachon P.H., Xu H., Liu L., Loechel F., Hayashi Y., Arahata K., Reed J.C., Wewer U.M., and Engvall E. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100 (1997) 1870-1881
52. Vivinus-Nebot M., Ticchioni M., Mary F., Hofman P., Quaranta V., Rousselle P., and Bernard A. Laminin 5 in the human thymus: control of T cell proliferation via α6-β4 integrins. J. Cell Biol. 144 (2006) 563-574
53. Wessler I., Kilbinger H., Bittinger F., Unger R., and Kirkpatrick C.J. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 72 (2003) 2055-2061
54. Wu A.M. Expression of binding properties of Gal/GalNAc reactive lectins by mammalian glycotopes (an updated report). Adv. Exp. Med. Biol. 491 (2004) 55-64
55. Xu H., Wu X.-R., Wewer U.M., and Engvall E. Murine muscular dystrophy caused by a mutation in the laminin alpha2 (Lama2) gene. Nat. Genet. 8 (1994) 297-302
56. Yoshihara Y. Visualizing selective neural pathways with WGA transgene: combination of neuroanatomy with gene technology. Neurosci. Res. 44 (2002) 133-140